Ecovyst Inc. reported third‑quarter 2025 results with sales of $204.9 million, up 33% year‑over‑year, and Adjusted EBITDA of $63.6 million, up 15% year‑over‑year. The Adjusted EBITDA margin improved to 31% from 28.1% in the same quarter last year.
The company posted a net loss of $79.3 million, a diluted loss per share of $0.69, largely due to discontinued operations from the sale of its Advanced Materials & Catalysts segment. Net income from continuing operations was $0.4 million, resulting in a diluted EPS of $0.00.
Ecovyst’s adjusted diluted EPS of $0.19 beat the consensus estimate of $0.17. Revenue was $204.9 million, slightly above the consensus estimate of $204.74 million.
The company reaffirmed its 2025 Adjusted EBITDA guidance at $238 million to $258 million and revised its full‑year sales guidance to $700 million to $740 million, with an Adjusted EBITDA guidance of approximately $170 million. The net debt leverage ratio is expected to remain below 1.5× after the sale proceeds are applied to debt.
Ecovyst completed the sale of its Advanced Materials & Catalysts segment to Technip Energies for $556 million, with net proceeds of $530 million. The transaction is expected to close in the first quarter of 2026 and will provide $450 million to $500 million of the proceeds to reduce long‑term debt. The divestiture aligns with the company’s strategy to focus on its core sulfuric acid services.
During the quarter, Ecovyst repurchased $5.5 million of common stock, bringing the cumulative repurchase program to $202.2 million. The program has no expiration date, underscoring the company’s commitment to returning capital to shareholders.
The sale of the Advanced Materials & Catalysts segment is viewed as a strategic move to strengthen Ecovyst’s balance sheet and enhance financial flexibility. Technip Energies expects the acquisition to be accretive, adding recurring revenue and expanding its catalyst capabilities.
Ecovyst’s Ecoservices segment remains the company’s primary revenue driver. Prior quarter and year comparisons show sales of $200.1 million and $153.9 million, and Adjusted EBITDA of $55.7 million and $55.1 million, respectively, underscoring the segment’s growth trajectory.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.